| 1 |
dpavlin |
1.1 |
<p align="center"><img src="p/MIXISlogo.jpg" width="276" height="206"></p> |
| 2 |
|
|
<p align="center"><b>A Biotechnology Company in Combinatorial Genetics</b></p> |
| 3 |
|
|
<p><b>MIXIS France</b>, Paris, is a biotechnology company working primarily in |
| 4 |
|
|
the field of Combinatorial Genetics. MIXIS owns a powerful proprietary technology, |
| 5 |
|
|
which easily and rapidly allows recombination of diverged genes and genomes |
| 6 |
|
|
to increase biodiversity and generate novel biosynthetic compounds. Because |
| 7 |
|
|
of this powerful technology, MIXIS enjoys a unique position in biodiversity |
| 8 |
|
|
research and industry. No other known technology offers the possibility of trans-species |
| 9 |
|
|
evolution, which can generate practically endless genetic diversity by interspecies |
| 10 |
|
|
recombination of entire genomes.</p> |
| 11 |
|
|
<p>By using appropriate screening systems, MIXIS will use this technology to identify |
| 12 |
|
|
novel products for life sciences including pharmaceutical drugs, novel proteins |
| 13 |
|
|
and organisms.</p> |
| 14 |
|
|
<p>It is the mission of MIXIS to be a reliable partner for Life-Science Companies, |
| 15 |
|
|
with whom MIXIS intends to bring these products rapidly to market.</p> |
| 16 |
|
|
<p align="right"><font size="-1"><i>"This technology is based on one of the most |
| 17 |
|
|
spectacular discoveries in the area of evolutionary molecular genetics."</i></font></p> |
| 18 |
|
|
<p align="right"><font size="-1">Joshua Lederberg, Nobel Laureate</font></p> |
Parent Directory
| 
Revision Log